Boston Scientific CorporationBSXNYSE
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$2.65B
↑ 138% above average
Average (9y)
$1.11B
Historical baseline
Range
High:$2.65B
Low:$-6.00M
CAGR
+25.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.65B | +55.3% |
| 2023 | $1.70B | +86.3% |
| 2022 | $914.00M | -30.5% |
| 2021 | $1.32B | +16.3% |
| 2020 | $1.13B | -17.7% |
| 2019 | $1.38B | +23016.7% |
| 2018 | $-6.00M | -100.5% |
| 2017 | $1.11B | +85.7% |
| 2016 | $596.00M | +68.8% |
| 2015 | $353.00M | - |